Identification of D179H, a novel missense GJB2 mutation in a Western Sicily family by Bartolotta, C. et al.
OTOLOGY
Identification of D179H, a novel missense GJB2 mutation
in a Western Sicily family
Caterina Bartolotta • Pietro Salvago •
Salvatore Cocuzza • Carmelo Fabiano •
Pietro Sammarco • Francesco Martines
Received: 21 April 2013 / Accepted: 19 June 2013
 Springer-Verlag Berlin Heidelberg 2013
Abstract The main purpose of this study was to describe
a novel missense mutation (p.D179H) found in a Western
Sicily family and to examine the genetic and audiologic
profiles of all family members by performing a GJB2 and
GJB6 mutations analysis and a complete audiologic
assessment. The proband was a 3-month-old infant with a
congenital profound sensorineural hearing loss; direct
sequencing of the GJB2 revealed the presence of a
c.35delG mutation in the heterozygous state and a hetero-
zygous G[C transition at nucleotide 535 in trans; this
novel mutation, called p.D179H, resulted in an aspartic
acid to histidine change at codon 179. It was also evi-
denced in the heterozygous state in two members of this
family, both with normal hearing. No GJB6 mutations were
evidenced in all subjects studied. Considering the geno-
typic and phenotypic analysis of all family members, we
suggest, differently from the p.D179 N mutation previ-
ously reported, a recessive mode of inheritance. Functional
studies on p.D179H have to be performed to confirm our
hypothesis.
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Introduction
Mutations in GJB2, a gene encoding Connexin 26 (Cx26)
protein on chromosome 13q11, are involved in the patho-
genesis of more than 50 % of congenital, autosomal
recessive, non-syndromic hearing loss (ARNSHL) [1].
Cx26 is one member of a family of gap-junction proteins
which oligomerize in groups of six subunits making up
hemichannels called ‘‘connexons’’. Each connexon can
bind with another from adjacent cells, forming intercellular
channels. They allow ions and small metabolites to pass
between cells for synchronized function and homeostasis of
tissues and organs. In the cochlea, Cx26 is expressed in the
supporting cells of the organ of Corti, the fibrocytes of the
spiral ligament and the basal cells of stria vascularis [2]
play a crucial role in K? recycling [3]. This cyclic ionic
flux is essential to maintain K? homeostasis by removing
K? from the hair cells during auditory transduction. In
addition, the permeability to Ca2?-mobilizing messenger
inositol triphosphate (IP3), regulated by Cx26, was dem-
onstrated to be necessary to generate an endocochlear
potential [4].
Over 90 mutations of GJB2 were identified (http://
davinci.crg.es/deafness), inherited in recessive or dominant
mode and influencing the audiological phenotype
differently.
Non-syndromic hearing loss can be linked also with
mutations of GJB6, a gene encoding Connexin 30 (Cx30)
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protein and coexpressed with GJB2 in the inner ear. Two
large deletions in GJB6 have been described and could
often occur with single recessive mutations in trans of the
GJB2, suggesting a possible ARNSHL digenic inheritance
[5, 6]. It has been also hypothesized that GJB6 deletions
are responsible for deafness in patients who also carry one
GJB2 recessive mutation in trans, as a result of the aboli-
tion of an as-yet-unidentified cis-regulatory element
responsible for the expression of the GJB2 gene in the
inner ear [7]. Furthermore, a deletion distant from the
transcriptional sites of both GJB2 and GJB6 and cosegre-
gating as a pathologic allele with a GJB2 mutation has
been linked with a reduced expression of Cx26 and Cx30
[8].
In 2003, Primignani et al. [9] discovered a novel dom-
inant GJB2 mutation (p.D179 N) identified in four deaf
members of a family from Southern Italy; they were all
heterozygous for a c.535 G[A mutation (resulting in an
aspartic acid to asparagine change at codon 179) and pre-
sented a mild to moderate post-lingual sensorineural
hearing loss (SNHL).
In this paper, we report a novel missense mutation of the
GJB2 (p.D179H), found in the heterozygous form in three
members of a Western Siciliy family; only one member,
who carried also a c.35delG mutation in trans, presented a
pre-lingual non-syndromic SNHL whereas the others were
normal hearing. Nevertheless, p.D179H causes a nucleo-
tide substitution at the same codon of p.D179 N, genetic
and audiological evaluation suggested a recessive mode of
inheritance.
Thus the identification of a new recessive GJB2 muta-
tion might help in understanding the relationship between
this gene and deafness phenotypes; moreover, it provides
additional evidences about the role of single GJB2 point
mutations in the pathogenesis of hearing defects and their
inheritance mode.
Materials and methods
We investigated a family from Western Sicily composed of
five members over three generations (Fig. 1). The proband
(III1) was a 3-month-old infant who was admitted to the
Audiology Section of the University of Palermo after
failing two neonatal hearing screenings (performed with
TEOAEs) in both ears; because the Audiology Section of
Palermo University represents the main speech and hearing
third level centre in Western Sicily, the infant was evalu-
ated with a global audiological assessment; environmental
risk factors for SNHL (JCIH 2007) [10] were investigated
through the compilation of a specific questionnaire by the
parents. An experienced audiologist and otorhinolaryn-
gologist examined the condition of the external auditory
canal and tympanic membrane with otoscopy, and nose,
throat, head and face in search of ear anomalies and syn-
dromic features related to hearing impairment [11–14].
The audiological assessment was performed by the same
qualified biomedical staff and consisted of performing
tympanometry measurement and recording auditory
brainstem responses (ABR) and TEOAEs.
After a clinical evaluation including micro-otoscopy, the
proband’s parents (II1,II2) and grandparents (I1,I2) were
evaluated with audiometric test (calculating air conduction
pure tone average thresholds at frequencies 0.5–1–2–4–
8 kHz for each ear) and tympanometry with stapedius
reflex testing.
All family members were tested for the molecular
analysis of the entire GJB2 and the GJB6 genes after
extracting DNA samples from peripheral blood. Blood
samples were taken from family members after obtaining
informed consent from each member and from the parents
of patient III1.
Genomic DNA was extracted classically from peripheral
blood samples by the salting-out method. Molecular anal-
ysis of the entire GJB2 gene was performed with PCR and
direct sequencing. Exon 1 was amplified with the primers
Cx1 forward (50-TCAAAGGAACTAGGAGATCGG-30)
and Cx1 reverse (50-CAAGGACGTGTGTGGTCCAG-30).
Exon 2 was amplified with the primers GAP1 forward (50-C
CTATGACAAACTAAGTTGGTTC-30) and CONN reverse
(50- GACAGCTGAGCACGGGTGCCTC-30).
USB ExoSAP-IT PCR Product Cleanup protocol
(37 C for 30 min and then 95 C for 5 min) was per-
formed to remove leftover primers and unincorporated
dNTPs (Affymetrix, Inc.).
Cleaned up PCR products were sequenced from both
ends, using the same primers as used for PCR reactions,
with Applied Biosystem (ABI) PRISM BigDye
Fig. 1 Pedigree and GJB2 genotypes for the study family segregating
non-syndromic recessive deafness
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Terminator v3.1 Cycle Sequencing Kits and analyzed with
ABI PRISM 3100 DNA automatic sequencer.
Furthermore, following PCR protocol and using primers
described by Del Castillo [5], we also checked the GJB6
gene to rule out the presence of deletions (del(GJB6-
D13S1830) and del(GJB6-D13S1854).
Results
The audiological assessment of the whole family revealed a
profound, bilateral and symmetric SNHL only in the
3-month-old infant (III1), evidenced by absent TEOAEs
and not recordable ABR (evocated by click stimuli at a
maximum level of 100 dB HL, Fig. 2); the other family
members instead presented a bilateral normal audiometric
threshold (\20 dB for the frequencies 0.5–1–2–4–8 kHz).
From the questionnaire answered by the parents it was
possible to exclude the main risk factors for SNHL, such as
family history of hearing impairment, consanguinity,
pregnant maternal infection (TORCH), ototoxic drugs
administration (furosemide, dexamethason, vancomycin,
gentamycin and tobramycin), prematurity, very low birth
weight (\1500 g), respiratory distress, intensive care in
excess of 5 days, hyperbilirubinemia requiring exchange
transfusion, perinatal infections and others conditions, as
recommended by JCIH 2007; no ear anomalies and syn-
dromic features related to hearing impairment were
identified.
All family members were tested for the molecular
analysis of GJB2 and GJB6 genes. Sequencing of GJB2
revealed that the proband (III1) presented a heterozygous
c.35delG mutation associated to a heterozygous c.535G[C
mutation resulting in an aspartic acid to histidine change at
codon 179 (p.D179H); individuals I2 and II2, who had
normal hearing, carried p.D179H in the heterozygous state
whereas subject II1 was only heterozygous for the
c.35delG mutation (Fig. 1).
Sequencing and deletional analysis of GJB6 were per-
formed in all family members to rule out, as stated previ-
ously, the hypothesis of a co-segregating pathological
allele; no mutations or deletions in the GJB6 gene were
found in any of the subjects tested.
Discussion
GJB2 mutations are the most frequent genetic cause of
congenital hearing loss, identified in over 50 % of AR-
NSHL. More than 90 different mutations of this gene were
recognized, characterized by a wide spectrum of pheno-
types [15], different modes of inheritance and deafness’
time of onset. GJB2 encodes Cx26, a member of a large
family of highly conserved proteins involved in the for-
mation of gap junctions which allows the direct transfer of
small molecules and ions between neighbouring cells. Each
member of this gap-junction family is constituted by four
transmembrane helices (TM1-4), N- and C-cytoplasmatic
termini, two extracellular loops (EC1-2) and one intracel-
lular loop. The N-terminal domain determines the locali-
zation of the nascent polypeptide chain in the endoplasmic
reticulum and the voltage gating with the first TM domain.
Similarly the C-terminal domain and the intracellular loop
regulate the pH gating. The EC loops are involved in the
connexon–connexon interactions forming a complete
channel. Because different amino acids of the EC domains
are conserved among either species and connexins, muta-
tions involving these regions are often responsible for a
Cx26 loss of function.
GJB2 allele variants have been classified as truncating
and non-truncating mutations [16]; truncating mutations,
such as the small deletions c.35delG, c.167delT, c.235delC
and the splice mutation IVS1?1G[A, included nonsense
mutations, deletions, insertions and duplications thatFig. 2 Auditory Brainstem Responses of subject III1
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introduce an anticipated stop codon; non-truncating muta-
tions, such as the p.M34T, the p.V95 M and the p.L90P,
contained amino acids substitutions and one inframe
deletion. Truncating mutations are often associated with a
greater degree of hearing loss than non-truncating muta-
tions; however, the presence in most patients of combined
mutations in the heterozygous state, makes difficult to
predict, on the basis of this classification, the severity of the
phenotype and the responsibility of each mutations in its
pathogenesis. In addition, functional studies of the Cx26
reported many times in literature, which demonstrated
complete loss of channel activity for mutations like
c.35delG and c.IVS1?1G[A [17, 18], resulted often dis-
crepant with the phenotype expected.
In the 2003 Primignani et al. described a novel non-
truncating GJB2 mutation found in three members of a
Southern Italy family suffering from post-lingual bilateral
SNHL limited to high frequencies; the direct sequencing of
the GJB2 gene evidenced a heterozygous G[A transition at
nucleotide 535, resulting in an aspartic acid to asparagine
substitution at codon 179 (p.D179 N). No mutations or
deletions in the GJB6 gene were found in any of the three
family members analyzed. The authors suggested a domi-
nant inheritance because of the presence in all hearing
impaired subjects of p.D179 N mutation in the heterozy-
gous state and the absence of a co-segregating pathological
allele of GJB6; the delayed onset of deafness in all family
members, frequent feature of dominant genetic hearing
loss, supported the hypothesis [9]. Furthermore, functional
studies performed on HeLa cells stably expressing the
previously described p.D179 N mutation, revealed how
this mutation only partially inhibited dye transfer of Cx26
and did not affect dye transfer of Cx30 [19, 20].
The novel non-truncating p.D179H mutation, which was
found in a Western Sicily family, occurs in the highly
conserved second EC loop of Cx26. The aspartic acid at
position 179, contained in this Cx26 domain, is conserved
in five different species (human, cow, sheep, rat and house
mouse) and in several human connexins, so it is crucial for
the activity of the gap junction.
Particularly p.D179H mutation, with a G[C transition at
nucleotide 535, replaces a negatively charged amino acid
(aspartic acid) with a positively charged amino acid (his-
tidine), what is predicted to cause a modification in local
conformation of EC2 and a defect in connexon–connexon
interaction.
Even if p.D179H mutation is localized in the same place
of p.D179 N, we think it could be possible to exclude, on
the basis of clinical and genetical findings, a dominant
pattern of inheritance for p.D179H; in fact individuals I1
and II1, who had normal hearing, carried this mutation in
the heterozygous state, while subject III1, who suffered
from SNHL, was found to be compound heterozygous for
Cx26 mutations (c.35delG/p.D179H) (Fig. 2); no muta-
tions or deletions in the GJB6 gene were found in all
individuals studied.
The identification of this novel GJB2 mutation high-
lights some critical data: the severity of the phenotype
associated with p.D179H is in contrast with Snoeckx
et al.’s classification, according to which non-truncating
mutations are associated with lower degree of hearing loss.
However, our case is a compound truncating (c.35delG)/
non-truncating (p.D179H) heterozygous, so we cannot
determine precisely the role of p.D179H in the pathogen-
esis of the phenotype. Moreover, considering the complex
structure and function of Cx26 gap junctions, it is really
difficult to predict the pathogenicity of this missense
mutation and to understand the different mode of inheri-
tance only on the basis of the amino acid substitution.
Finally, functional studies have to be performed to study
the effects of p.D179H on Cx26 channel activity and fur-
ther support would be provided not only by the finding of a
homozygous affected subject, but also by the other affected
compound heterozygotes in other families.
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